Hawaii 2025 Regular Session

Hawaii House Bill HB205

Introduced
1/16/25  
Refer
1/21/25  
Report Pass
1/30/25  

Caption

Relating To Workers' Compensation.

Impact

The proposed changes to the existing statutes on workers' compensation would not only provide clarity regarding payment rates but could also help reduce overall insurance expenses. By setting a cap on how much can be charged for these specific drugs, the bill aims to prevent excessive billing practices that had previously burdened the workers' compensation system. This alignment has the potential to lower the premiums that businesses pay for workers' compensation insurance, contributing to a more sustainable financial model for employers across Hawaii.

Summary

House Bill 205, introduced in the 2025 legislative session, aims to address ambiguities surrounding reimbursement rates for nonprescription drugs, over-the-counter drugs, or nonlegend drugs under the workers' compensation system. The bill seeks to establish clear payment rates that ensure these drugs are compensated at no more than cost plus forty percent. This legislative measure responds to concerns about inflated pricing for these medications, which can lead to increased workers' compensation insurance costs for employers and insurers alike. By clarifying reimbursement protocols, the bill intends to create a more predictable and fair pricing environment for nonprescription necessities used in treating work-related injuries.

Sentiment

Sentiments surrounding HB 205 appear generally supportive, particularly among business and employer communities who are eager to see a reduction in rising insurance costs. Stakeholders argue that the bill contributes positively to the efficiency and fairness of the workers' compensation framework. However, there might be concerns about how this regulation could affect the availability and accessibility of necessary medications, which may also stem from the adjustments in pricing that could deter providers from dispensing certain medications.

Contention

While the bill aims to positively impact cost management and clarity in reimbursement rates, it may also raise discussions regarding the adequacy of the established payment limits and their implications on patient care. Critics might argue that a stringent limit could lead to providers being less inclined to dispense certain necessary medications, potentially putting injured workers at risk of insufficient care for their treatment. The balance between reasonable cost control and ensuring access to medically necessary drugs will likely be a focal point of debate as the bill progresses through the legislature.

Companion Bills

No companion bills found.

Similar Bills

MN SF646

Licensee fee reduction for manufacturers and wholesalers of medical gas

ME LD1128

An Act to Modernize the Formulary for Naturopathic Doctors

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

MN SF3121

Pharmacy intern provisions modifications

ME LD163

An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives

HI SB1043

Relating To Taxation.

TX SB1500

Relating to written protocols for certain nonprescription drugs under Medicaid and civil liability related to those protocols.

LA HB606

Exempts prescription drugs and insulin from local sales and use taxes